Stratec SE (0RAR.L)
EUR 23.01
(-0.01%)
EUR 23.01
(-0.01%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 261.91 Million EUR | -4.63% |
| 2022 | 274.62 Million EUR | -4.42% |
| 2021 | 287.33 Million EUR | 14.89% |
| 2020 | 250.09 Million EUR | 12.84% |
| 2019 | 221.64 Million EUR | 18.01% |
| 2018 | 187.81 Million EUR | -10.46% |
| 2017 | 209.76 Million EUR | 13.44% |
| 2016 | 184.91 Million EUR | 25.89% |
| 2015 | 146.88 Million EUR | 1.4% |
| 2014 | 144.86 Million EUR | 13.22% |
| 2013 | 127.95 Million EUR | 4.51% |
| 2012 | 122.42 Million EUR | 0.19% |
| 2011 | 122.19 Million EUR | 14.49% |
| 2010 | 106.73 Million EUR | 34.1% |
| 2009 | 79.58 Million EUR | 17.86% |
| 2008 | 67.52 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 48.41 Million EUR | 23.49% |
| 2004 | 39.2 Million EUR | 19.51% |
| 2003 | 32.8 Million EUR | 16.67% |
| 2002 | 28.12 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 68.2 Million EUR | 34.07% |
| 2024 Q3 | 57.22 Million EUR | -16.09% |
| 2024 Q1 | 50.87 Million EUR | -31.47% |
| 2023 Q2 | 64.52 Million EUR | 6.7% |
| 2023 Q1 | 60.47 Million EUR | -9.7% |
| 2023 FY | 261.91 Million EUR | -4.63% |
| 2023 Q4 | 74.23 Million EUR | 18.44% |
| 2023 Q3 | 62.67 Million EUR | -2.87% |
| 2022 Q3 | 70.46 Million EUR | 14.0% |
| 2022 FY | 274.62 Million EUR | -4.42% |
| 2022 Q4 | 66.97 Million EUR | -4.95% |
| 2022 Q1 | 75.38 Million EUR | 21.76% |
| 2022 Q2 | 61.8 Million EUR | -18.02% |
| 2021 Q2 | 83.77 Million EUR | 16.36% |
| 2021 FY | 287.33 Million EUR | 14.89% |
| 2021 Q3 | 69.65 Million EUR | -16.85% |
| 2021 Q1 | 71.99 Million EUR | 1.38% |
| 2021 Q4 | 61.91 Million EUR | -11.11% |
| 2020 Q3 | 59.71 Million EUR | -5.01% |
| 2020 FY | 250.09 Million EUR | 12.84% |
| 2020 Q4 | 71.01 Million EUR | 18.93% |
| 2020 Q1 | 56.5 Million EUR | -6.73% |
| 2020 Q2 | 62.86 Million EUR | 11.25% |
| 2019 Q3 | 50.68 Million EUR | -19.15% |
| 2019 Q2 | 62.69 Million EUR | 31.5% |
| 2019 FY | 221.64 Million EUR | 18.01% |
| 2019 Q4 | 60.58 Million EUR | 19.52% |
| 2019 Q1 | 47.67 Million EUR | -10.37% |
| 2018 FY | 187.81 Million EUR | -10.46% |
| 2018 Q1 | 41.6 Million EUR | -29.13% |
| 2018 Q2 | 49.29 Million EUR | 18.49% |
| 2018 Q3 | 45.69 Million EUR | -7.29% |
| 2018 Q4 | 53.19 Million EUR | 16.4% |
| 2017 Q4 | 58.69 Million EUR | 16.59% |
| 2017 Q3 | 50.34 Million EUR | -1.7% |
| 2017 Q2 | 51.21 Million EUR | 3.44% |
| 2017 Q1 | 49.51 Million EUR | -15.48% |
| 2017 FY | 209.76 Million EUR | 13.44% |
| 2016 Q1 | 31.21 Million EUR | -21.34% |
| 2016 FY | 184.91 Million EUR | 25.89% |
| 2016 Q2 | 46.81 Million EUR | 49.96% |
| 2016 Q3 | 48.3 Million EUR | 3.18% |
| 2016 Q4 | 58.57 Million EUR | 21.27% |
| 2015 Q1 | 34.54 Million EUR | -12.72% |
| 2015 FY | 146.88 Million EUR | 1.4% |
| 2015 Q4 | 39.68 Million EUR | 6.72% |
| 2015 Q3 | 37.18 Million EUR | 4.86% |
| 2015 Q2 | 35.46 Million EUR | 2.66% |
| 2014 Q2 | 34.68 Million EUR | 0.9% |
| 2014 Q3 | 36.22 Million EUR | 4.46% |
| 2014 FY | 144.86 Million EUR | 13.22% |
| 2014 Q1 | 34.37 Million EUR | -8.42% |
| 2014 Q4 | 39.58 Million EUR | 9.26% |
| 2013 Q3 | 31.03 Million EUR | 2.74% |
| 2013 Q1 | 29.17 Million EUR | -16.27% |
| 2013 Q2 | 30.2 Million EUR | 3.55% |
| 2013 FY | 127.95 Million EUR | 4.51% |
| 2013 Q4 | 37.53 Million EUR | 20.93% |
| 2012 Q3 | 29.34 Million EUR | -0.2% |
| 2012 Q1 | 28.84 Million EUR | -31.4% |
| 2012 Q2 | 29.4 Million EUR | 1.95% |
| 2012 Q4 | 34.84 Million EUR | 18.74% |
| 2012 FY | 122.42 Million EUR | 0.19% |
| 2011 FY | 122.19 Million EUR | 14.49% |
| 2011 Q2 | 29.46 Million EUR | 16.17% |
| 2011 Q4 | 42.04 Million EUR | 32.36% |
| 2011 Q3 | 31.76 Million EUR | 7.79% |
| 2011 Q1 | 25.36 Million EUR | -67.9% |
| 2010 Q3 | 26.11 Million EUR | 14.06% |
| 2010 FY | 106.73 Million EUR | 34.1% |
| 2010 Q4 | 79.02 Million EUR | 202.59% |
| 2010 Q1 | 20.22 Million EUR | -65.02% |
| 2010 Q2 | 22.89 Million EUR | 13.21% |
| 2009 Q3 | -14.77 Million EUR | -174.56% |
| 2009 Q2 | 19.81 Million EUR | 18.36% |
| 2009 Q4 | 57.81 Million EUR | 491.26% |
| 2009 FY | 79.58 Million EUR | 17.86% |
| 2009 Q1 | 16.74 Million EUR | 0.0% |
| 2008 FY | 67.52 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 48.41 Million EUR | 23.49% |
| 2004 FY | 39.2 Million EUR | 19.51% |
| 2003 FY | 32.8 Million EUR | 16.67% |
| 2002 FY | 28.12 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | 57.482% |
| Guerbet SA | 795.65 Million EUR | 67.082% |
| Nexus AG | 241.45 Million EUR | -8.47% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | 50.56% |
| Revenio Group Oyj | 96.57 Million EUR | -171.197% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 92.236% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 92.287% |
| LNA Santé SA | 736.08 Million EUR | 64.418% |
| Siemens Healthineers AG | 22.36 Billion EUR | 98.829% |
| Medios AG | 1.78 Billion EUR | 85.325% |
| Equasens Société anonyme | 219.78 Million EUR | -19.165% |